Clinical Trial Update: Role of IL 12 and IL 23 as Potential Biomarkers in Diagnosis of Early Crohn's Disease

View source ↗

Summary

This completed clinical trial evaluated whether interleukin-12 and interleukin-23 could serve as biomarkers for diagnosing early Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Tanta University | Conditions: Interleukin 12, Interleukin 23 | Status: COMPLETED